P2X7受体中的遗传变异:药物开发的机遇和挑战
Justin S Y Cheah1,2, Kristen K Skarratt3, Stephen J Fuller3
1Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.
International journal of molecular sciences
|November 13, 2025
概括
P2X7受体 (P2X7R) 的遗传变异可能解释了为什么针对它的药物在临床试验中失败. 了解P2X7R多样性对于未来在炎症和神经系统疾病中的治疗成功至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
背景情况:
- P2X7受体 (P2X7R) 是细胞应激反应的关键组成部分,由细胞外ATP激活.
- 它在炎症和神经系统疾病中的参与使其成为一个有前途的治疗点.
- 不幸的是,以前使用P2X7R抗剂的临床试验取得了有限的成功.
研究的目的:
- 调查P2X7R抗剂试验中缺乏临床疗效的潜在原因.
- 探索受体多态,替代拼接和膜组成对P2X7R功能的影响.
- 确定改善在疾病状态下P2X7R的精确准的策略.
主要方法:
- 对P2X7R遗传学,拼接和膜相互作用的现有文献的审查.
- 对影响临床试验结果的因素的分析.
- 讨论P2X7R研究的结构发现和计算方法.
主要成果:
- 受体多态,替代拼接和细胞膜组成被确定为影响P2X7R功能的重要因素.
- 建议P2X7R的遗传变异是临床试验失败的主要原因.
- 在理解受体单元型和拼接变体方面的差距阻碍了药物开发.
结论:
- 建议在招生前对基因定型试验参与者进行基因定型,以考虑P2X7R遗传变异性.
- 实验室研究必须考虑表达P2X7R的细胞的膜组成.
- 需要采用全面的协作方法来精确准P2X7R,利用计算方法来解决变异性并改善治疗结果.
更多相关视频
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.7K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.7K
Dose-Response Relationship: Selectivity and Specificity
9.5K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.5K
Drug-Receptor Interactions
7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
G Protein-coupled Receptors
16.4K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.4K
Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K
Drug-Receptor Interaction: Agonist
3.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.8K


